MEDICAL SPECIALTIES
Medical Specialties
Focused on hematologic diseases, inherited blood disorders, and hematologic malignancies — providing international patients with disease education, record-preparation guidance, and specialist review pathways.
Hematologic Diseases
Alpha Thalassemia
Assessment priorities, genetic counseling, transfusion management, and further treatment options for alpha-globin gene-related anemia.
View details →Beta Thalassemia
Severity assessment, long-term management, hematopoietic stem cell transplantation, and preparation for care in China.
View details →Sickle Cell Disease
Evaluation of anemia, pain crises and organ complications, with guidance on comprehensive treatment and follow-up pathways.
View details →Hemophilia
Bleeding risk assessment for clotting factor deficiencies, replacement therapy, complication management, and cross-border care preparation.
View details →Rare & Genetic Metabolic Diseases
Gaucher Disease
Enzyme and genetic testing, organ involvement assessment, long-term treatment options, and multidisciplinary management priorities.
View details →Wilson Disease
Hepatic and neurological assessment for copper metabolism disorders, plus standardized treatment, monitoring, and long-term management.
View details →Hematologic Malignancies
Relapsed / Refractory ALL
Disease re-evaluation, immunotherapy, cell therapy, and specialist consultation pathways for relapsed or refractory ALL.
View details →Relapsed / Refractory Multiple Myeloma
Stratified assessment, novel agents, cell therapy, and individualized treatment planning for relapsed or refractory myeloma.
View details →Relapsed / Refractory Lymphoma
Re-classification, response assessment, immunotherapy, and cell therapy consultation for relapsed or refractory lymphoma.
View details →Treatment Direction Guides
Guide to Inherited Blood Disorder Evaluation
Learn how diagnosis, genetic testing, family risk, and long-term management are reviewed for inherited blood disorders.
View details →Genetic Testing & Precision Therapy Assessment
Review pre-test counseling, positive/negative/uncertain results, family risk, and next treatment-direction questions.
View details →Hematopoietic Stem Cell Transplant Assessment
Understand disease status, prior therapy, HLA typing, donor information, and transplant-risk discussion topics.
View details →CAR-T Cell Therapy Evaluation Guide
For relapsed or refractory hematologic malignancies, learn how pathology, target testing, prior therapy, and fitness records are reviewed.
View details →Rare Disease Comprehensive Evaluation
Review genetic testing, organ involvement, multidisciplinary management, and family-risk questions for rare diseases.
View details →